SEP-226330

N/A

Report date: 2022/02/18 14:33:03
NME

Base Information

Drug NameSEP-226330
Drug Alias NameSEP-0226330SEP-226330
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNorepinephrine transporter inhibitorsDopamine transporter antagonists
TargetsNorepinephrine transporterDopamine transporter
Therapy Area/IndicationsRestless Legs Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSunovion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSunovion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRestless Legs Syndrome

Other Information

ATC CodeN/A
Related LinksN/A